Source: FinanzNachrichten

SkylineDx: SkylineDx Presents Landmark Study on Merlin CP-GEP beyond SLNB prediction: Transforming Melanoma Risk Assessment

Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death.Validates Merlin CP-GEP's prognostic power: Identifying tumor...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Dharminder Chahal's photo - Co-Founder & CEO of SkylineDx

Co-Founder & CEO

Dharminder Chahal

CEO Approval Rating

87/100

Read more